← Patient library Booklet · print or save as PDF All types
AURORA · Glioma · Full booklet v0.1 draft · September 2026
Patient education — not medical advice aurora.health/glioma
Patient & family booklet

Glioma

What the words on a pathology report mean, and how they shape what comes next.

Guides
50
Terms defined
265
Reading level
Age 11–12
Reviewed
September 2026
How to use this booklet

Print it and bring it. Write on it — the margins are wide on purpose. The questions on the last pages are the part clinicians tell us patients most often forget to ask, so tick the ones you want answered before you go in.

Contents

  1. 01 When to seek help urgently
  2. 02 Start here — the guides to read first
  3. 03 Words you will hear
  4. 04 Questions to ask your clinician
  5. 05 Where else to look
  6. 06 About this booklet
01

When to seek help urgently

This page is first because it matters most. If any of these is happening, contact your care team, an urgent care line, or emergency services — do not wait for a scheduled appointment.

A new seizure, or seizures that change in pattern
Sudden weakness, numbness, or difficulty speaking
A severe headache with vomiting or drowsiness
New confusion or a change in personality
Fever while on chemotherapy or steroids
Sudden vision loss
My care team phone
Out-of-hours number
02

Start here

Start with the report vocabulary — type, grade, markers — because everything else in your care follows from it.

01 Glioma 101 — What It Is, What It Isn't, and What to Do After Diagnosis 2 min

Learn what a glioma is, the main types and grades, how molecular markers shape diagnosis, and what to do after hearing the word "glioma."

aurora.health/glioma/glioma-101-what-it-means
02 How the Brain Works — Glial Cells, Neurons, and Where Gliomas Come From 2 min

Understand neurons, glial cells, and how the brain is organized — the biology behind where gliomas start and why location matters.

aurora.health/glioma/glial-cells-where-gliomas-come-from
03 The Types of Glioma — Astrocytoma, Oligodendroglioma, Glioblastoma, Ependymoma, and More 2 min

A plain-language map of the main glioma types and how doctors now sort them by cell type, grade, and molecular markers.

aurora.health/glioma/types-of-glioma
04 Understanding Glioma Grades — Low-Grade vs High-Grade and What Grade Means 2 min

What glioma grade means, the difference between low-grade and high-grade tumors, and why grade alone doesn't tell the whole story.

aurora.health/glioma/glioma-grades-explained
05 The 2021 WHO Brain Tumor Classification — Why Molecular Markers Now Matter 2 min

Why your glioma diagnosis now includes genetic details, what changed in the 2021 WHO classification, and what it means for you.

aurora.health/glioma/2021-who-brain-tumor-classification
06 IDH-Mutant vs IDH-Wildtype Glioma — What This Difference Means for You 2 min

IDH status is one of the most important facts about a glioma. Learn what IDH-mutant and IDH-wildtype mean for prognosis and treatment.

aurora.health/glioma/idh-mutant-vs-wildtype-glioma
03

Words you will hear

Eighteen of the 265 terms in the full dictionary — the ones most likely to appear on a report or be said in a consultation.

Glioma
A glioma is a tumor that arises from the glial cells of the brain or spinal cord, the most common type of primary brain tumor.
Brain tumor
A brain tumor is an abnormal growth of cells in or around the brain, which may be benign or malignant and may begin in the brain or spread from elsewhere.
Primary brain tumor
A primary brain tumor is one that begins in the brain itself, as opposed to spreading there from cancer elsewhere; gliomas are primary brain tumors.
Metastatic (secondary) brain tumor
A metastatic brain tumor is cancer that has spread to the brain from elsewhere in the body, distinct from a glioma, which begins in the brain.
Central nervous system (CNS) tumor
A central nervous system tumor is a tumor of the brain or spinal cord, the category that includes gliomas under the WHO classification.
Glial cells
Glial cells are the supportive cells of the nervous system that surround and assist neurons, and the cells from which gliomas arise.
Neoplasm
A neoplasm is an abnormal, excessive growth of cells, the general medical term for a tumor, including gliomas.
Benign versus malignant (brain tumors)
Benign and malignant describe whether a tumor is non-cancerous or cancerous, though in the brain even benign tumors can cause problems by their location.
Diffuse glioma
A diffuse glioma is a glioma that infiltrates surrounding brain tissue, the most common and clinically important category of glioma in adults.
Circumscribed glioma
A circumscribed glioma is a glioma with relatively well-defined borders that does not widely infiltrate the brain, often more amenable to surgery.
WHO Classification of CNS Tumors
The WHO Classification of Tumors of the Central Nervous System is the international standard system for naming, grouping, and grading brain and spinal cord tumors, including gliomas.
WHO CNS5 (2021 classification)
WHO CNS5 is the 2021 fifth edition of the brain tumor classification, which for the first time integrates molecular markers into how gliomas are defined and graded.
Tumor grade
Tumor grade is a measure of how aggressive a tumor is expected to be, based on its appearance and molecular features, central to predicting glioma behavior.
WHO grade (1–4)
WHO grades 1 to 4 indicate increasing aggressiveness of a glioma, with grade 1 the least aggressive and grade 4 the most aggressive.
Low-grade glioma
A low-grade glioma is a slower-growing glioma (generally grade 1 or 2), often with a more favorable outlook than high-grade gliomas.
High-grade glioma
A high-grade glioma is a faster-growing, more aggressive glioma (generally grade 3 or 4), which requires prompt and intensive treatment.
Histopathology (histology)
Histopathology is the examination of tumor tissue under a microscope, a foundational step in diagnosing and grading gliomas.
Integrated (layered) diagnosis
An integrated diagnosis combines microscopic and molecular findings into a single, precise glioma diagnosis, the standard approach in the modern WHO system.
04

Questions to ask

Tick what you want answered. Appointments move fast — a written list is the difference between leaving with answers and leaving with new worries.

What type and grade is it, and which molecular markers were tested?
What is the goal of surgery — diagnosis, debulking, or complete removal?
Am I eligible for any clinical trials, here or elsewhere?
Which of my symptoms do you think are explained by this condition, and which are not?
What symptoms should make me contact you immediately rather than wait?
If we watch and wait, what exactly are we watching for, and how often?
Can I have a copy of my imaging and the report to keep?
Who is my main point of contact between appointments?
What should school or my employer know, and will you put it in writing?
How would you feel about me getting a second opinion?
My own questions
05

Where else to look

Independent organisations that support people with this condition. AURORA is not affiliated with any of them and does not receive anything for listing them.

Directory pending verification. Contact details and scope are being confirmed with each organisation before this booklet is published. Names are listed without links until that is done.

National Brain Tumor Society Patient charity

Research funding, trial navigation and patient support programmes.

The Brain Tumour Charity Patient charity

UK information, support line and clinical trial signposting.

American Brain Tumor Association Patient charity

Condition education, care navigation and support communities.

Musella Foundation Patient charity

Brain tumour trial database and copay assistance programmes.

06

About this booklet

Version 0.1 draft — pending clinical review
Last reviewed September 2026
Written by AURORA patient-education working group
Clinical sign-off Not yet obtained
Licence CC BY-SA 4.0
Source aurora.health/glioma
What this is not

This booklet is patient education. It describes groups of people, not you. It cannot examine you, read your scan, or know your history — and reading it creates no clinician–patient relationship. Every decision about your care belongs to you and a qualified clinician who knows your case.